Immunological mechanisms in pleural disease
- PMID: 12662014
- DOI: 10.1183/09031936.03.00403902
Immunological mechanisms in pleural disease
Abstract
The pleural membrane consisting of pleural mesothelial cells and its underlying connective tissue layers play a critical role in immunological responses in both local and systemic diseases. The pleura, because of its intimate proximity to the lung, is positioned to respond to inflammatory changes in the lung parenchyma. Importantly, several systemic diseases have a predilection for expression on the pleural surface. Immunological responses in the pleura include the development of pleural permeability and pleural effusion formation as well as the development of pleural fibrosis and scarring. Under either circumstance, the normal functioning of the pleura is impaired and has multiple consequences leading to increased morbidity and even mortality for the patient. During infections in the pleural space, the pleural mesothelium responds by actively recruiting inflammatory phagocytic cells and allowing the movement of proteins from the vascular compartment into the pleural space. The release of chemokines by the pleural mesothelium allows for directed migration of phagocytic cells from the basilar surface of the pleura towards the apical surface. In malignant disease, the pleura may be the site of primary tumours such as mesothelioma and also the site for malignant metastatic deposits. Certain cancers such as cancers of the breast, ovary, lung, and stomach have a predilection for the pleural mesothelium. The process whereby malignant cells attach to the pleural mesothelium and develop autocrine mechanisms for survival in the pleural space are elucidated in this review. The pleura functions not only as a mechanical barrier, but also as an immunologically and metabolically responsive membrane that is involved in maintaining a dynamic homeostasis in the pleural space.
Similar articles
-
Pathophysiology of the pleura.Respiration. 2008;75(2):121-33. doi: 10.1159/000113629. Epub 2008 Mar 6. Respiration. 2008. PMID: 18332619 Review.
-
Pathophysiology of pleural space infections.Semin Respir Infect. 1999 Mar;14(1):9-17. Semin Respir Infect. 1999. PMID: 10197393 Review.
-
Anatomy and physiology of the pleural space.Chest Surg Clin N Am. 1994 Aug;4(3):391-403. Chest Surg Clin N Am. 1994. PMID: 7953475 Review.
-
[Physiopathology of pleural diseases].Rev Prat. 1997 Jun 15;47(12):1294-7. Rev Prat. 1997. PMID: 9248094 Review. French.
-
The pleura in health and disease.Semin Respir Crit Care Med. 2010 Dec;31(6):649-73. doi: 10.1055/s-0030-1269826. Epub 2011 Jan 6. Semin Respir Crit Care Med. 2010. PMID: 21213198 Review.
Cited by
-
Mechanisms of T-lymphocyte accumulation during experimental pleural infection induced by Mycobacterium bovis BCG.Infect Immun. 2008 Dec;76(12):5686-93. doi: 10.1128/IAI.00133-08. Epub 2008 Sep 22. Infect Immun. 2008. PMID: 18809659 Free PMC article.
-
Making cold malignant pleural effusions hot: driving novel immunotherapies.Oncoimmunology. 2019 Jan 22;8(4):e1554969. doi: 10.1080/2162402X.2018.1554969. eCollection 2019. Oncoimmunology. 2019. PMID: 30906651 Free PMC article. Review.
-
The pleural mesothelium in development and disease.Front Physiol. 2014 Aug 1;5:284. doi: 10.3389/fphys.2014.00284. eCollection 2014. Front Physiol. 2014. PMID: 25136318 Free PMC article.
-
Ventilator-induced Lung Injury Promotes Inflammation within the Pleural Cavity.Am J Respir Cell Mol Biol. 2024 Jul;71(1):43-52. doi: 10.1165/rcmb.2023-0332OC. Am J Respir Cell Mol Biol. 2024. PMID: 38767348 Free PMC article.
-
Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy.Front Immunol. 2017 Aug 25;8:999. doi: 10.3389/fimmu.2017.00999. eCollection 2017. Front Immunol. 2017. PMID: 28890718 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical